Animal model of sensorineural hearing loss associated with Lassa virus infection

Journal of Virology

Volumn 90, Issue 6, 2016, Pages 2920-2927

  Yun, Nadezhda E ^a   Ronca, Shannon ^a   Tamura, Atsushi ^a   Koma, Takaaki ^a   Seregin, Alexey V ^a   Dineley, Kelly T ^b   Miller, Milagros ^a   Cook, Rebecca ^a   Shimizu, Naoki ^a   Walker, Aida G ^a   Smith, Jeanon N ^a   Fair, Joseph N ^b   Wauquier, Nadia ^b   Bockarie, Bayon ^b   Khan, Sheik Humarr ^c   Makishima, Tomoko ^a   Paessler, Slobodan ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b METABIOTA INC   (United States)

^c MINISTRY OF HEALTH AND SANITATION   (Sierra Leone)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPIDEMIC; EXPERIMENTAL MODEL; HAIR CELL; HUMAN; LASSA FEVER; LASSA VIRUS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MORTALITY; MOUSE; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SIERRA LEONE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS VIRULENCE; ANIMAL; COCHLEAR NERVE; COMPLICATION; CYTOCHEMISTRY; DISEASE MODEL; HEARING LOSS, SENSORINEURAL; INNER EAR; ISOLATION AND PURIFICATION; MICROSCOPY; PATHOLOGY; VIRULENCE;

ANIMALS; COCHLEAR NERVE; DISEASE MODELS, ANIMAL; DISEASE OUTBREAKS; EAR, INNER; HEARING LOSS, SENSORINEURAL; HISTOCYTOCHEMISTRY; HUMANS; LASSA FEVER; LASSA VIRUS; MICE; MICROSCOPY; SIERRA LEONE; VIRULENCE;

EID: 84961147687     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02948-15     Document Type: Article

References (34)

1. Eze KC, Salami TAT, Eze IC, Pogoson AE, Omordia N, Ugochukwu MO. 2010. High Lassa Fever activity in northern part of Edo State, Nigeria: reanalysis of confirmatory test results. Afr J Health Sci 17:52-56.
2. Buchmeier MJ, de la Torre JC, Peters CJ. 2013. Arenaviridae, p 1283-1303. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
3. McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, Smith ES, Trippel S, Tong TC. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155:445-455.
4. Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, Fisher-Hoch SP. 1990. Acute sensorineural deafness in Lassa fever. JAMA 264:2093-2096.
5. Rybak LP. 1990. Deafness associated with Lassa fever. JAMA 264:2119-2119.
6. Cohen BE, Durstenfeld A, Roehm PC. 2014. Viral causes of hearing loss: a review for hearing health professionals. Trends Hear 18: 2331216514541361.
7. Anderson JL, Levy PT, Leonard KB, Smyser CD, Tychsen L, Cole FS. 2014. Congenital lymphocytic choriomeningitis virus: when to consider the diagnosis. J Child Neurol 29:837-842.
8. Barton LL, Mets MB, Beauchamp CL. 2002. Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am J Obstet Gynecol 187:1715-1716.
9. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. 1997. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 130: 624-630.
10. Schraff SA, Brown DK, Schleiss MR, Meinzen-Derr J, Greinwald JH, Choo DI. 2007. The role ofCMVinflammatory genes in hearing loss. Otol Neurotol 28:964-969.
11. van der Westhuizen Y, Swanepoel de W, Heinze B, Hofmeyr LM. 2013. Auditory and otological manifestations in adults with HIV/AIDS. Int J Audiol 52:37-43.
12. Campo A, del Cerro M, Foss JA, Ison JR, Orr JL, Warren PH, Monjan AA. 1985. Impairment in auditory and visual function follows perinatal viral infection in the rat. Int J Neurosci 27:85-90.
13. Casetta I, Ciorba A, Cesnik E, Trevisi P, Tugnoli V, Bovo R. 2011. West Nile virus neuroinvasive disease presenting with acute flaccid paralysis and bilateral sensorineural hearing loss. J Neurol 258:1880-1881.
14. McBride W, Gill KR, Wiviott L. 2006. West Nile virus infection with hearing loss. J Infect 53:e203-e205.
15. Bonthius DJ. 2012. Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult. Semin Pediatr Neurol 19:89-95.
16. Yun NE, Seregin AV, Walker DH, Popov VL, Walker AG, Smith JN, Miller M, de la Torre JC, Smith JK, Borisevich V, Fair JN, Wauquier N, Grant DS, Bockarie B, Paessler S. 2013. Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol 87: 10908-10911. http://dx.doi.org/10.1128/jvi.01433-13.
17. McGuire B, Fiorillo B, Ryugo DK, Lauer AM. 2015. Auditory nerve synapses persist in ventral cochlear nucleus long after loss of acoustic input in mice with early-onset progressive hearing loss. Brain Res 1605: 22-30.
18. Yun NE, Poussard AL, Seregin AV, Walker AG, Smith JK, Aronson JF, Smith JN, Soong L, Paessler S. 2012. Functional interferon system is required for clearance of Lassa virus. J Virol 86:3389-3392.
19. Threadgill DW, Yee D, Matin A, Nadeau JH, Magnuson T. 1997. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm Genome 8:390-393.
20. Spandow O, Anniko M, Moller AR. 1988. The round window as access route for agents injurious to the inner ear. Am J Otolaryngol 9:327-335.
21. Caye-Thomasen P, Worsoe L, Brandt CT, Miyazaki H, Ostergaard C, Frimodt-Moller N, Thomsen J. 2009. Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis. Laryngoscope 119:1560-1570.
22. Liao BS, Byl FM, Adour KK. 1992. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause. Otolaryngol Head Neck Surg 106:226-229.
23. Ibekwe TS, Okokhere PO, Asogun D, Blackie FF, Nwegbu MM, Wahab KW, Omilabu SA, Akpede GO. 2011. Early-onset sensorineural hearing loss in Lassa fever. Eur Arch Otorhinolaryngol 268:197-201.
24. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. 1986. Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:20-26.
25. Oldstone MB, Campbell KP. 2011. Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response. Virology 411:170-179.
26. Rambukkana A, Kunz S, Min J, Campbell KP, Oldstone MB. 2003. Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination. Proc Natl Acad Sci U S A 100:16071-16076.
27. Yun NE, Walker DH. 2012. Pathogenesis of Lassa fever. Viruses 4:2031-2048.
28. Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE, Jr. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A 93:7673-7678.
29. Tanabe Y, Nishibori T, Su L, Arduini RM, Baker DP, David M. 2005. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J Immunol 174:609-613.
30. Gil MP, Salomon R, Louten J, Biron CA. 2006. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 107:987-993.
31. Gamero AM, Larner AC. 2000. Signaling via the T cell antigen receptor induces phosphorylation of Stat1 on serine 727. J Biol Chem 275:16574-16578.
32. Lafont V, Decker T, Cantrell D. 2000. Antigen receptor signal transduction: activating and inhibitory antigen receptors regulate STAT1 serine phosphorylation. Eur J Immunol 30:1851-1860.
33. Wenta N, Strauss H, Meyer S, Vinkemeier U. 2008. Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations. Proc Natl Acad Sci U S A 105:9238-9243.
34. Quigley M, Huang X, Yang Y. 2008. STAT1 signaling in CD8 T cells is required for their clonal expansion and memory formation following viral infection in vivo. J Immunol 180:2158-2164.